Efficacy and Tolerability Study of V501 in Japanese Males (V501-122)

NCT01862874 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1124

Enrollment

INDUSTRY

Sponsor class

Conditions

Anogenital Human Papilloma Virus Infection
Condyloma Acuminata

Interventions

BIOLOGICAL: V501
BIOLOGICAL: Placebo

Sponsor

Merck Sharp & Dohme LLC